NCT07086638View on ClinicalTrials.gov

ROS-Scavenging Nanozyme Combined With Thermotherapy Alleviate Radiation Dermatitis in Patients With Head and Neck Cancer

NARecruitingINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

July 25, 2025

Primary Completion Date

September 25, 2025

Study Completion Date

October 25, 2025

Conditions
Radiation Dermatitis
Interventions
DRUG

Photo-responsive nanozyme

The nanozyme scavenges ROS at the site of dermatitis and simultaneously responds to NIR light to generate mild heat, thereby promoting the healing of radiation-induced skin injury.

Trial Locations (1)

Unknown

RECRUITING

Sichuan University West China Hospital, Chengdu

All Listed Sponsors
lead

West China Hospital

OTHER

NCT07086638 - ROS-Scavenging Nanozyme Combined With Thermotherapy Alleviate Radiation Dermatitis in Patients With Head and Neck Cancer | Biotech Hunter | Biotech Hunter